THEMIS MEDICARE
Back to Cashflow Statement
|
THEMIS MEDICARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-26 Cr | ₹-8.77 Cr | ₹0.14 Cr | ₹-18 Cr | ₹-26 Cr |
What is the latest Cash Flow from Financing Activities ratio of THEMIS MEDICARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-26 Cr |
| Mar2024 | ₹-8.77 Cr |
| Mar2023 | ₹0.14 Cr |
| Mar2022 | ₹-18 Cr |
| Mar2021 | ₹-26 Cr |
How is Cash Flow from Financing Activities of THEMIS MEDICARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-26 Cr | Negative | |
| Mar2024 | ₹-8.77 Cr | Negative | |
| Mar2023 | ₹0.14 Cr | Positive | |
| Mar2022 | ₹-18 Cr | Negative | |
| Mar2021 | ₹-26 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹922.8 Cr | -3.9% | 3.4% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -3.9% |
3.4% |
-25.7% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses